AEterna Zentaris Subsidiary Atrium Biotechnologies Acquires Canadian Business Multichem(27 Jan 2005) AEterna Zentaris Inc. announced the closing of the acquisition of all Multichem assets by its subsidiary Atrium Biotechnologies Inc., for the total amount of 23.8 million canadian dollars of which 22.2 million canadian dollars were paid in cash at ...
Top
